No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
ABEO240517P7500
- 2.95
- +0.30+11.32%
15min DelayClose May 15 15:59 ET
2.95High2.95Low
2.95Open2.65Pre Close1 Volume11 Open Interest7.50Strike Price295.00Turnover896.63%IV-11.89%PremiumMay 17, 2024Expiry Date2.79Intrinsic Value100Multiplier1DDays to Expiry0.16Time Value100Contract SizeAmericanOptions Type-0.6385Delta0.1182Gamma1.41Leverage Ratio-0.3102Theta-0.0003Rho-0.90Eff Leverage0.0013Vega
Intraday
- 5D
- 1D
News
Express News | Abeona Therapeutics Shares Are Trading Higher. The Company Reported Q1 Financial Results
ABEONA THERAPEUTICS INC. Q1 Loss Increases, Misses Estimates
Express News | Abeona Therapeutics Estimates That Its Current Cash And Cash Equivalents, Restricted Cash And Short-term Investments Of $62.7M, Credit Facility, And Proceeds Of $75M From Underwritten Offering In May Is Expected To Provide Cash Runway Into 2026
Express News | Abeona Therapeutics Q1 2024 GAAP EPS $(1.16) Misses $(0.51) Estimate
Abeona Therapeutics | 10-Q: Quarterly report
Express News | Abeona Therapeutics Inc - Closed $75 Mln Underwritten Offering in May, Extending Expected Cash Runway Into 2026
Comments
$Abeona Therapeutics(ABEO.US$ I was just talking about this and it had a nice pop
1
$Abeona Therapeutics(ABEO.US$
NEWS
Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Abeona Therapeutics Inc. announced the pricing of an underwritten offering of common stock and pre-funded warrants, expected to generate approximately $75 million in gross proceeds. The offering includes both new and existing investors, with the funds intended for the resubmission of its BLA, commercialization of its product candidate pz-cel, and ...
NEWS
Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
Abeona Therapeutics Inc. announced the pricing of an underwritten offering of common stock and pre-funded warrants, expected to generate approximately $75 million in gross proceeds. The offering includes both new and existing investors, with the funds intended for the resubmission of its BLA, commercialization of its product candidate pz-cel, and ...
$Abeona Therapeutics(ABEO.US$ This has entered my watchlist , A lot of Insider buying and we are also awaiting Approval for one of their Drugs at the end of this month , so we watch and wait to enter here !!!
1
📣 3 PDUFAs left in April! See summary 👇
🗓️ Last week’s PDUFAs:
$Pfizer(PFE.US$ : Approved 4/26 🎉
⇨ BEQVEZ (fidanacogene elaparvovec-dzkt)
▹ Hemophilia B
▹ BLA
▹ PDUFA date: Q2 2024
$Day One Biopharmaceuticals(DAWN.US$ : Approved 4/23 🎉
⇨ OJEMDA (tovorafenib)
▹ Pediatric low-grade glioma
▹ NDA
▹ PDUFA date: 4/30/24
$ImmunityBio(IBRX.US$ : Approved 4/22 🎉
⇨ Anktiva + BCG
▹ Bladder cancer
▹ resubmitted BLA
▹ PDUFA date: 4/23/24
$Abeona Therapeutics(ABEO.US$ : CRL 4/22 🙁
⚠...
🗓️ Last week’s PDUFAs:
$Pfizer(PFE.US$ : Approved 4/26 🎉
⇨ BEQVEZ (fidanacogene elaparvovec-dzkt)
▹ Hemophilia B
▹ BLA
▹ PDUFA date: Q2 2024
$Day One Biopharmaceuticals(DAWN.US$ : Approved 4/23 🎉
⇨ OJEMDA (tovorafenib)
▹ Pediatric low-grade glioma
▹ NDA
▹ PDUFA date: 4/30/24
$ImmunityBio(IBRX.US$ : Approved 4/22 🎉
⇨ Anktiva + BCG
▹ Bladder cancer
▹ resubmitted BLA
▹ PDUFA date: 4/23/24
$Abeona Therapeutics(ABEO.US$ : CRL 4/22 🙁
⚠...
11
4
$Abeona Therapeutics(ABEO.US$ Officer O'Malley Brendan M. purchased 8,600 shares of common stock on Apr 25, 2024 at an average price of $3.24 for a total value of $27,864. Officer Vazzano Joseph Walter purchased 5,608 shares of common stock on Apr 25, 2024 at an average price of $3.14 for a total value of $17,609.12.
3
Read more
MoneyMovesss : Swing it